Loading clinical trials...
Loading clinical trials...
A Minimal-Risk, Multi-Center, Prospective, Clinical Trial to Evaluate the PrevisEA Device for Predicting Gastrointestinal Impairment
Conditions
Interventions
PrevisEA device
Locations
8
United States
Adventist Health System/Sunbelt, Inc. d/b/a AdventHealth Orlando
Orlando, Florida, United States
Northwestern University
Chicago, Illinois, United States
Spectrum Health Blodgett Hospital
Grand Rapids, Michigan, United States
University of Minnesota
Minneapolis, Minnesota, United States
Mayo Clinic
Rochester, Minnesota, United States
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Start Date
September 14, 2021
Primary Completion Date
September 1, 2024
Completion Date
December 1, 2024
Last Updated
March 13, 2024
NCT06165523
NCT05080907
NCT03100409
NCT00936130
NCT00814086
NCT00436774
Lead Sponsor
Entac Medical Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions